transplantologiyaТрансплантологияTransplantologiya. The Russian Journal of Transplantation2074-05062542-0909IPO Association of Transplantologists10.23873/2074-0506-2011-0-4-26-29transplantologiya-320Research ArticleОБЗОРНЫЕ СТАТЬИ И ЛЕКЦИИREVIEW ARTICLES AND LECTURESСиндром малой доли печени после обширных резекций и родственной трансплантации печениSmall for size syndrome after major resections and living-related liver transplantationАлихановР. Б.AlikhanovR. B.ЧжаоА. В.ChzhaoA. V.ФГУ Институт хирургии им. А.В. Вишневского;
ФФМ МГУ им. М.В. ЛомоносоваRussian FederationФГУ Институт хирургии им. А.В. ВишневскогоRussian Federation201121082018042629Copyright © Алиханов Р.Б., Чжао А.В., 20182018Алиханов Р.Б., Чжао А.В.Alikhanov R.B., Chzhao A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.jtransplantologiya.ru/jour/article/view/320
Синдром малой доли печени после обширных резекций и родственной трансплантации печени.
Small for size syndrome after major resections and living-related liver transplantation.
ReferencesStrategies for safer liver surgery and partial liver transplantation/P.A. Clavien //N. Engl. J. Med. -2007. -Vol. 356. -P. 1545-1559.Strategies for safer liver surgery and partial liver transplantation/P.A. Clavien //N. Engl. J. Med. -2007. -Vol. 356. -P. 1545-1559.Alopecia, ascites, and incomplete regeneration after 85 to 90 per cent liver resection/T.E. Starzl //Am. J. Surg. 1975. -Vol. 129. -P. 587-590.Alopecia, ascites, and incomplete regeneration after 85 to 90 per cent liver resection/T.E. Starzl //Am. J. Surg. 1975. -Vol. 129. -P. 587-590.Dahm, F. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications/F. Dahm, P. Georgiev, P.A Clavien//Am. J. Transplant. -2005. -Vol. 5. -P. 2605-2610.Dahm, F. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications/F. Dahm, P. Georgiev, P.A Clavien//Am. J. Transplant. -2005. -Vol. 5. -P. 2605-2610.The «50-50 criteria» on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy/Литература S. Balzan //Ann. Surg. -2005. -Vol. 242. -P. 824-828.The «50-50 criteria» on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy/Литература S. Balzan //Ann. Surg. -2005. -Vol. 242. -P. 824-828.«State of theart» in liver resection and living donor liver transplantation: a worldwidesurvey of 100 liver centers/Breitenstein //World J. Surg. 2009. -Vol. 33. -P. 797-803.«State of theart» in liver resection and living donor liver transplantation: a worldwidesurvey of 100 liver centers/Breitenstein //World J. Surg. 2009. -Vol. 33. -P. 797-803.Critical graft size in adult-to-adult living donor Liver Transplantation: impact of the recipient’s disease/M. Ben-Haim //Liver Transpl. -2001. -Vol. 7. -P. 948-953.Critical graft size in adult-to-adult living donor Liver Transplantation: impact of the recipient’s disease/M. Ben-Haim //Liver Transpl. -2001. -Vol. 7. -P. 948-953.Iakova, P. Aging reduces proliferative capacities of liver by switching pathways of C/EBPalpha growth arrest/P. Iakova, S.S. Awad, N.A. Timchenko//Cell. -2003. -Vol. 113 -P. 495-506.Iakova, P. Aging reduces proliferative capacities of liver by switching pathways of C/EBPalpha growth arrest/P. Iakova, S.S. Awad, N.A. Timchenko//Cell. -2003. -Vol. 113 -P. 495-506.The age-associated decline of glycogen synthase kinase 3beta plays a critical role in the inhibition of liver regeneration/J. Jin //Mol. Cell. Biol. -2009. -Vol. 29. -P. 3867-3880.The age-associated decline of glycogen synthase kinase 3beta plays a critical role in the inhibition of liver regeneration/J. Jin //Mol. Cell. Biol. -2009. -Vol. 29. -P. 3867-3880.The impact of donor age on living donor liver Transplantation/T. Ikegami //Transplantation. -2000. -Vol. 70. -P. 1703-1707.The impact of donor age on living donor liver Transplantation/T. Ikegami //Transplantation. -2000. -Vol. 70. -P. 1703-1707.Hepatic steatosis as a potential risk factor for major hepatic resection/K~E. Behrns //J. Gastrointest. Surg. -1998. -Vol. 2. -P. 292-298.Hepatic steatosis as a potential risk factor for major hepatic resection/K~E. Behrns //J. Gastrointest. Surg. -1998. -Vol. 2. -P. 292-298.Impact of steatosis on perioperative outcome following hepatic resection/D.A. Kooby //J. Gastrointest. Surg. 2003. -Vol. 7. -P. 1034-1044.Impact of steatosis on perioperative outcome following hepatic resection/D.A. Kooby //J. Gastrointest. Surg. 2003. -Vol. 7. -P. 1034-1044.Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study/McCormack L. //Ann. Surg. 2007. -Vol. 245. -P. 923-930.Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study/McCormack L. //Ann. Surg. 2007. -Vol. 245. -P. 923-930.Use of steatotic graft in living-donor liver Transplantation/Y. Soejima //Transplantation. -2003. -Vol. 76. -P. 344-348.Use of steatotic graft in living-donor liver Transplantation/Y. Soejima //Transplantation. -2003. -Vol. 76. -P. 344-348.A.M. El-Badry Assessment of hepatic steatosis by expert pathologists: the end of a gold standard/A.M. El-Badry //Ann. Surg.-2010. -Vol. 250. -P. 691-697.A.M. El-Badry Assessment of hepatic steatosis by expert pathologists: the end of a gold standard/A.M. El-Badry //Ann. Surg.-2010. -Vol. 250. -P. 691-697.Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial/B. Nordlinger .//Lancet. -2008. -Vol. 371. -P. 1007-1016.Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial/B. Nordlinger .//Lancet. -2008. -Vol. 371. -P. 1007-1016.The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation/D. Hind //Health Technol. Assess. -2008. -Vol. 12. -P. iii-ix, xi-162.The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation/D. Hind //Health Technol. Assess. -2008. -Vol. 12. -P. iii-ix, xi-162.Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression/K. Man //Ann. Surg. -2003. -Vol. 237. -P. 256-264.Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression/K. Man //Ann. Surg. -2003. -Vol. 237. -P. 256-264.Excessive portal venous inflow as a cause of allograft dysfunction in small-for-size living donor liver transplantation/T. Shimamura //Trans. Proc. ~ 2001. -Vol. 33. -P. 1331.Excessive portal venous inflow as a cause of allograft dysfunction in small-for-size living donor liver transplantation/T. Shimamura //Trans. Proc. ~ 2001. -Vol. 33. -P. 1331.Modulation of portal graft inflow: a necessity in adult living donor liver transplantation?/R. Troisi //Ann. Surg. -2003. -Vol. 237. -P. 429-436.Modulation of portal graft inflow: a necessity in adult living donor liver transplantation?/R. Troisi //Ann. Surg. -2003. -Vol. 237. -P. 429-436.Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome/A.J. Demetris //Am. J. Surg. Pathol. -2006. -Vol. 30. -P. 986-993.Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome/A.J. Demetris //Am. J. Surg. Pathol. -2006. -Vol. 30. -P. 986-993.Lautt, W.W. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response/W.W. Lautt//Am. J. Physiol. -1985. -Vol. 249. -P. G549-G556.Lautt, W.W. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response/W.W. Lautt//Am. J. Physiol. -1985. -Vol. 249. -P. G549-G556.Portal hyperperfusion: mechanism of injury and stimulus for regeneration in porcine small-for-size transplantation/C. Fondevila //Liver Transpl. -2010/-Mar., Vol. 16(3). -P. 364-374.Portal hyperperfusion: mechanism of injury and stimulus for regeneration in porcine small-for-size transplantation/C. Fondevila //Liver Transpl. -2010/-Mar., Vol. 16(3). -P. 364-374.Liang TSinusoidal microcirculatory changes after small-for-size liver transplantation in rats/J. Li //Transpl. Int. -2010. -Sep., Vol. 23(9). -P. 924-933. -Epub. -2010. -Feb. 19.Liang TSinusoidal microcirculatory changes after small-for-size liver transplantation in rats/J. Li //Transpl. Int. -2010. -Sep., Vol. 23(9). -P. 924-933. -Epub. -2010. -Feb. 19.Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization/EK. Abdalla //Arch. Surg. -2002. -Vol. 137. -P. 675-680.Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization/EK. Abdalla //Arch. Surg. -2002. -Vol. 137. -P. 675-680.Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome/D. Ribero //Br. J. Surg. -2007. -Vol. 94. -P. 1386-1394.Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome/D. Ribero //Br. J. Surg. -2007. -Vol. 94. -P. 1386-1394.Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab/B. Aussilhou //Ann. Surg. Oncol. -2009. -Vol. 16. -P. 1553-1559.Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab/B. Aussilhou //Ann. Surg. Oncol. -2009. -Vol. 16. -P. 1553-1559.Selective hemiportocaval shunt based on portal vein pressure for small-for-size graft in adult living donor liver transplantation/T. Yamada //Am. J. Transplant. -2008. -Apr., Vol. 8(4). -P. 847-853.Selective hemiportocaval shunt based on portal vein pressure for small-for-size graft in adult living donor liver transplantation/T. Yamada //Am. J. Transplant. -2008. -Apr., Vol. 8(4). -P. 847-853.Left lobe adult-to-adult living donor Liver Transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome/J.F. Botha //Liver Transpl. -2010. -May., Vol. 16(5). -P. 649-657.Left lobe adult-to-adult living donor Liver Transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome/J.F. Botha //Liver Transpl. -2010. -May., Vol. 16(5). -P. 649-657.Endovascular closure of a hemiportocaval shunt after small-for-size adult-to-adult left lobe living donor Liver Transplantation/J.F. Botha //Liver Transpl. -2009. -Dec., Vol. 15(12). -P. 1671-1675.Endovascular closure of a hemiportocaval shunt after small-for-size adult-to-adult left lobe living donor Liver Transplantation/J.F. Botha //Liver Transpl. -2009. -Dec., Vol. 15(12). -P. 1671-1675.Method for spontaneous constriction and closure of portocaval shunt using a ligamentum teres hepatis in small-for-size graft liver Transplantation/Y. Sato //Transplantation. -2010. -Dec. 15, Vol. 90(11). -P. 1200-1203.Method for spontaneous constriction and closure of portocaval shunt using a ligamentum teres hepatis in small-for-size graft liver Transplantation/Y. Sato //Transplantation. -2010. -Dec. 15, Vol. 90(11). -P. 1200-1203.Mesorenal shunt using inferior mesenteric vein and left renal vein in a case of LDLT/H. Kanazawa //Transpl. Int. -2009. -Dec., Vol. 22(12). -P. 1189-1192.Mesorenal shunt using inferior mesenteric vein and left renal vein in a case of LDLT/H. Kanazawa //Transpl. Int. -2009. -Dec., Vol. 22(12). -P. 1189-1192.Splenectomy improves survival by increasing arterial blood supply in a rat model of reduced-size liver/C. Eipel //Transpl. Int. -2010. -Oct., Vol. 23(10). -P. 998-1007.Splenectomy improves survival by increasing arterial blood supply in a rat model of reduced-size liver/C. Eipel //Transpl. Int. -2010. -Oct., Vol. 23(10). -P. 998-1007.Beneficial effects of splenectomy on liver regeneration in a rat model of massive hepatectomy/N-SQ. Yan-Sun Ren //Hepatobiliary Pancreat Dis Int. -2011.Beneficial effects of splenectomy on liver regeneration in a rat model of massive hepatectomy/N-SQ. Yan-Sun Ren //Hepatobiliary Pancreat Dis Int. -2011.Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a longterm prospective study/F. Piscaglia //Hepatology. -1999. -Jul, Vol. 30(1). -P. 58-64.Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a longterm prospective study/F. Piscaglia //Hepatology. -1999. -Jul, Vol. 30(1). -P. 58-64.Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis/M. Navasa //Hepatology. -1993. -Mar., Vol. 17(3). -P. 355-60.Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis/M. Navasa //Hepatology. -1993. -Mar., Vol. 17(3). -P. 355-60.Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients/A. Hadengue //Hepatology. -1993. -Feb., Vol. 17(2). -P. 175-178.Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients/A. Hadengue //Hepatology. -1993. -Feb., Vol. 17(2). -P. 175-178.Role of splenectomy in human liver transplantation under modern-day immunosuppression/F. Samimi //Dig Dis Sci. -1998. -Sep., Vol. 43(9). -P. 1931-1937.Role of splenectomy in human liver transplantation under modern-day immunosuppression/F. Samimi //Dig Dis Sci. -1998. -Sep., Vol. 43(9). -P. 1931-1937.Single-center experience of 253 portal vein thrombosis patients undergoing liver transplantation in China/C. Pan /j Transplant. Proc. -2009. -Nov., Vol. 41(9). -P. 3761-3765.Single-center experience of 253 portal vein thrombosis patients undergoing liver transplantation in China/C. Pan /j Transplant. Proc. -2009. -Nov., Vol. 41(9). -P. 3761-3765.Effects of prophylactic splenic artery modulation on portal overperfusion and liver regeneration in smallfor-size graft/Y. Umeda //Transplantation. -2008. -Sep. 15., Vol. 86(5). -P. 673-680.Effects of prophylactic splenic artery modulation on portal overperfusion and liver regeneration in smallfor-size graft/Y. Umeda //Transplantation. -2008. -Sep. 15., Vol. 86(5). -P. 673-680.Splenic abscess after splenic artery ligation in living donor liver transplantation: a case report/D. Balci //Transplant. Proc. -2008. -Jun., Vol. 40(5). -P. 1786-1788.Splenic abscess after splenic artery ligation in living donor liver transplantation: a case report/D. Balci //Transplant. Proc. -2008. -Jun., Vol. 40(5). -P. 1786-1788.Reconstruction of the hepatic vein in reduced size hepatic transplantation/J.C. Emond //Surg. Gynecol. Obstet. -1993. -Jan., Vol. 176(1). -P. 11-17.Reconstruction of the hepatic vein in reduced size hepatic transplantation/J.C. Emond //Surg. Gynecol. Obstet. -1993. -Jan., Vol. 176(1). -P. 11-17.Surgical techniques and innovations in living related liver transplantation/K. Tanaka //Ann. Surg. -1993. -Jan., Vol. 217(1). -P. 82-91.Surgical techniques and innovations in living related liver transplantation/K. Tanaka //Ann. Surg. -1993. -Jan., Vol. 217(1). -P. 82-91.Outflow tract reconstruction in living donor liver Transplantation/V.H. de Villa //Transplantation. -2000. -Dec 15., Vol. 70(11). -P. 1604-1618.Outflow tract reconstruction in living donor liver Transplantation/V.H. de Villa //Transplantation. -2000. -Dec 15., Vol. 70(11). -P. 1604-1618.
The authors declare that there are no conflicts of interest present.